Histone posttranslational modifications (HPTMs) are crucial epigenetic mechanisms regulating various biological events. Different types of HPTMs characterize and shape functional chromatin states alone or in combination, and dedicated effector proteins selectively recognize these modifications for gene expression. The dysregulation of HPTM recognition events takes part in human diseases. With the application of mass spectrometry- (MS-) based proteomics, novel histone lysine acylation has been successively discovered, e.g., propionylation, butyrylation, 2-hydroxyisobutyrylation, β-hydroxybutyrylation, malonylation, succinylation, crotonylation, glutarylation, and lactylation. These nine types of modifications expand the repertoire of HPTMs and regulate chromatin remodeling, gene expression, cell cycle, and cellular metabolism. Recent researches show that HPTMs have a close connection with the pathogenesis of cancer, metabolic diseases, neuropsychiatric disorders, infertility, kidney diseases, and acquired immunodeficiency syndrome (AIDS). This review focuses on the chemical structure, sites, functions of these novel HPTMs, and underlying mechanism in gene expression, providing a glimpse into their complex regulation in health and disease.
Keyphrases
- gene expression
- dna methylation
- mass spectrometry
- cell cycle
- genome wide
- healthcare
- public health
- cell proliferation
- endothelial cells
- liquid chromatography
- mental health
- health information
- papillary thyroid
- high resolution
- capillary electrophoresis
- high performance liquid chromatography
- squamous cell carcinoma
- transcription factor
- health promotion
- multiple sclerosis
- risk assessment
- gas chromatography
- dendritic cells
- ms ms
- antiretroviral therapy
- adipose tissue
- oxidative stress
- human health
- immune response
- induced pluripotent stem cells
- polycystic ovary syndrome
- lymph node metastasis
- young adults
- amino acid